Bionano Genomics Reports Third Quarter 2022 Financial Results and Highlights Recent Business ...
Bionano Genomics, Inc. (Nasdaq: BNGO), today reported financial results for the third quarter ended September 30, 2022
By Bionano Genomics
Published - Nov 03, 2022, 04:06 PM ET
Last Updated - Jul 24, 2024, 05:20 AM EDT
– 55% year-over-year revenue growth in Q3 2022
– On track to achieve all 2022 ELEVATE! milestones
– Strong balance sheet with $180.2 million in cash, cash equivalents, and available-for-sale securities at the end of Q3 2022
– Conference call today, November 3rd, 2022 at 4:30 PM ET
